Newly Discovered Hormone Keeps Breastfeeding Mothers' Bones Strong
UCSF and UC Davis Researchers Uncover Maternal Brain Hormone CCN3
Promising New Therapeutic Treatment for Osteoporosis
A groundbreaking study published in Nature has revealed the discovery of a new hormone, dubbed Maternal Brain Hormone (CCN3), that plays a crucial role in maintaining bone strength in breastfeeding women. Researchers at UCSF and UC Davis conducted the study, which involved experiments in mice.
Previous research had established the existence of a protein related to parathyroid hormone, but it was not until this study that scientists identified CCN3 as a distinct hormone with significant osteoanabolic (bone-building) properties.
"Our findings establish CCN3 as a potentially new therapeutic osteoanabolic hormone for both sexes," said the lead researcher. "This discovery opens up exciting possibilities for treating osteoporosis, a condition that affects millions of people worldwide."
0 Comments